A carregar...

Rosuvastatin Attenuates Myocardial Ischemia-Reperfusion Injury via Upregulating miR-17-3p-Mediated Autophagy

Myocardial diseases usually appear ischemic. Reperfusion therapy is one of the effective methods that can improve clinical therapeutic efficacy. However, reperfusion results in myocardial injury named I/R injury. Rosuvastatin (RS) is HMG-CoA reductase inhibitor. We investigated the role of RS in the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Reprogram
Main Authors: Wang, Xiaoqin, Chen, Jinghan, Huang, Xiaojiao
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc., publishers 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6918854/
https://ncbi.nlm.nih.gov/pubmed/31730378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cell.2018.0053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!